Medical Care

Global Oligonucleotide API Manufacturing Services Market Research Report 2025

The global market for Oligonucleotide API Manufacturing Services was valued at US$ 894 million in the year 2024 and is projected to reach a revised size of US$ 1798 million by 2031, growing at a CAGR of 10.6% during the forecast period.
Oligonucleotide API manufacturing services focus on providing high-quality oligonucleotide synthesis, purification, and scalable production to meet the research and commercialization needs of the biopharmaceutical industry. These services cover the entire process from nucleic acid sequence design and process development to optimization and large-scale GMP (Good Manufacturing Practice) production, ensuring high purity, high yield, and consistency. The manufacturing process utilizes advanced solid-phase synthesis (SPPS) technology, combined with quality control measures such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to ensure compliance with regulatory standards. Oligonucleotide APIs are widely used in gene therapy, vaccine development, mRNA therapeutics, and RNA interference (RNAi)-based treatments, driving advancements in precision medicine.
North American market for Oligonucleotide API Manufacturing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oligonucleotide API Manufacturing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Oligonucleotide API Manufacturing Services in Pharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Oligonucleotide API Manufacturing Services include Danaher(IDT), Merck, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Nippon Shokubai, Eurogentec, Ajinomoto Bio-Pharma, PeptiStar, Bachem, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide API Manufacturing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide API Manufacturing Services.
The Oligonucleotide API Manufacturing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligonucleotide API Manufacturing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide API Manufacturing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Danaher(IDT)
Merck
Eurofins Scientific
Thermo Fisher Scientific
Agilent Technologies
Nippon Shokubai
Eurogentec
Ajinomoto Bio-Pharma
PeptiStar
Bachem
CordenPharma
Guangzhou RiboBio
Hongene Biotech
WuXi AppTec
Veliter
Ribobay Pharma
ChemExpress
Asymchem
Segment by Type
ASO
siRNA
miRNA
saRNA
Aptamer
Others
Segment by Application
Pharmaceuticals
Scientific Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide API Manufacturing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotide API Manufacturing Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ASO
1.2.3 siRNA
1.2.4 miRNA
1.2.5 saRNA
1.2.6 Aptamer
1.2.7 Others
1.3 Market by Application
1.3.1 Global Oligonucleotide API Manufacturing Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide API Manufacturing Services Market Perspective (2020-2031)
2.2 Global Oligonucleotide API Manufacturing Services Growth Trends by Region
2.2.1 Global Oligonucleotide API Manufacturing Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oligonucleotide API Manufacturing Services Historic Market Size by Region (2020-2025)
2.2.3 Oligonucleotide API Manufacturing Services Forecasted Market Size by Region (2026-2031)
2.3 Oligonucleotide API Manufacturing Services Market Dynamics
2.3.1 Oligonucleotide API Manufacturing Services Industry Trends
2.3.2 Oligonucleotide API Manufacturing Services Market Drivers
2.3.3 Oligonucleotide API Manufacturing Services Market Challenges
2.3.4 Oligonucleotide API Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide API Manufacturing Services Players by Revenue
3.1.1 Global Top Oligonucleotide API Manufacturing Services Players by Revenue (2020-2025)
3.1.2 Global Oligonucleotide API Manufacturing Services Revenue Market Share by Players (2020-2025)
3.2 Global Top Oligonucleotide API Manufacturing Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oligonucleotide API Manufacturing Services Revenue
3.4 Global Oligonucleotide API Manufacturing Services Market Concentration Ratio
3.4.1 Global Oligonucleotide API Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide API Manufacturing Services Revenue in 2024
3.5 Global Key Players of Oligonucleotide API Manufacturing Services Head office and Area Served
3.6 Global Key Players of Oligonucleotide API Manufacturing Services, Product and Application
3.7 Global Key Players of Oligonucleotide API Manufacturing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotide API Manufacturing Services Breakdown Data by Type
4.1 Global Oligonucleotide API Manufacturing Services Historic Market Size by Type (2020-2025)
4.2 Global Oligonucleotide API Manufacturing Services Forecasted Market Size by Type (2026-2031)
5 Oligonucleotide API Manufacturing Services Breakdown Data by Application
5.1 Global Oligonucleotide API Manufacturing Services Historic Market Size by Application (2020-2025)
5.2 Global Oligonucleotide API Manufacturing Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oligonucleotide API Manufacturing Services Market Size (2020-2031)
6.2 North America Oligonucleotide API Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oligonucleotide API Manufacturing Services Market Size by Country (2020-2025)
6.4 North America Oligonucleotide API Manufacturing Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oligonucleotide API Manufacturing Services Market Size (2020-2031)
7.2 Europe Oligonucleotide API Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oligonucleotide API Manufacturing Services Market Size by Country (2020-2025)
7.4 Europe Oligonucleotide API Manufacturing Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotide API Manufacturing Services Market Size (2020-2031)
8.2 Asia-Pacific Oligonucleotide API Manufacturing Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oligonucleotide API Manufacturing Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Oligonucleotide API Manufacturing Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oligonucleotide API Manufacturing Services Market Size (2020-2031)
9.2 Latin America Oligonucleotide API Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oligonucleotide API Manufacturing Services Market Size by Country (2020-2025)
9.4 Latin America Oligonucleotide API Manufacturing Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotide API Manufacturing Services Market Size (2020-2031)
10.2 Middle East & Africa Oligonucleotide API Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oligonucleotide API Manufacturing Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Oligonucleotide API Manufacturing Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher(IDT)
11.1.1 Danaher(IDT) Company Details
11.1.2 Danaher(IDT) Business Overview
11.1.3 Danaher(IDT) Oligonucleotide API Manufacturing Services Introduction
11.1.4 Danaher(IDT) Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.1.5 Danaher(IDT) Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Oligonucleotide API Manufacturing Services Introduction
11.2.4 Merck Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Oligonucleotide API Manufacturing Services Introduction
11.3.4 Eurofins Scientific Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.3.5 Eurofins Scientific Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Oligonucleotide API Manufacturing Services Introduction
11.4.4 Thermo Fisher Scientific Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Oligonucleotide API Manufacturing Services Introduction
11.5.4 Agilent Technologies Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.5.5 Agilent Technologies Recent Development
11.6 Nippon Shokubai
11.6.1 Nippon Shokubai Company Details
11.6.2 Nippon Shokubai Business Overview
11.6.3 Nippon Shokubai Oligonucleotide API Manufacturing Services Introduction
11.6.4 Nippon Shokubai Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.6.5 Nippon Shokubai Recent Development
11.7 Eurogentec
11.7.1 Eurogentec Company Details
11.7.2 Eurogentec Business Overview
11.7.3 Eurogentec Oligonucleotide API Manufacturing Services Introduction
11.7.4 Eurogentec Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.7.5 Eurogentec Recent Development
11.8 Ajinomoto Bio-Pharma
11.8.1 Ajinomoto Bio-Pharma Company Details
11.8.2 Ajinomoto Bio-Pharma Business Overview
11.8.3 Ajinomoto Bio-Pharma Oligonucleotide API Manufacturing Services Introduction
11.8.4 Ajinomoto Bio-Pharma Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.8.5 Ajinomoto Bio-Pharma Recent Development
11.9 PeptiStar
11.9.1 PeptiStar Company Details
11.9.2 PeptiStar Business Overview
11.9.3 PeptiStar Oligonucleotide API Manufacturing Services Introduction
11.9.4 PeptiStar Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.9.5 PeptiStar Recent Development
11.10 Bachem
11.10.1 Bachem Company Details
11.10.2 Bachem Business Overview
11.10.3 Bachem Oligonucleotide API Manufacturing Services Introduction
11.10.4 Bachem Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.10.5 Bachem Recent Development
11.11 CordenPharma
11.11.1 CordenPharma Company Details
11.11.2 CordenPharma Business Overview
11.11.3 CordenPharma Oligonucleotide API Manufacturing Services Introduction
11.11.4 CordenPharma Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.11.5 CordenPharma Recent Development
11.12 Guangzhou RiboBio
11.12.1 Guangzhou RiboBio Company Details
11.12.2 Guangzhou RiboBio Business Overview
11.12.3 Guangzhou RiboBio Oligonucleotide API Manufacturing Services Introduction
11.12.4 Guangzhou RiboBio Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.12.5 Guangzhou RiboBio Recent Development
11.13 Hongene Biotech
11.13.1 Hongene Biotech Company Details
11.13.2 Hongene Biotech Business Overview
11.13.3 Hongene Biotech Oligonucleotide API Manufacturing Services Introduction
11.13.4 Hongene Biotech Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.13.5 Hongene Biotech Recent Development
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Details
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Oligonucleotide API Manufacturing Services Introduction
11.14.4 WuXi AppTec Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.14.5 WuXi AppTec Recent Development
11.15 Veliter
11.15.1 Veliter Company Details
11.15.2 Veliter Business Overview
11.15.3 Veliter Oligonucleotide API Manufacturing Services Introduction
11.15.4 Veliter Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.15.5 Veliter Recent Development
11.16 Ribobay Pharma
11.16.1 Ribobay Pharma Company Details
11.16.2 Ribobay Pharma Business Overview
11.16.3 Ribobay Pharma Oligonucleotide API Manufacturing Services Introduction
11.16.4 Ribobay Pharma Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.16.5 Ribobay Pharma Recent Development
11.17 ChemExpress
11.17.1 ChemExpress Company Details
11.17.2 ChemExpress Business Overview
11.17.3 ChemExpress Oligonucleotide API Manufacturing Services Introduction
11.17.4 ChemExpress Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.17.5 ChemExpress Recent Development
11.18 Asymchem
11.18.1 Asymchem Company Details
11.18.2 Asymchem Business Overview
11.18.3 Asymchem Oligonucleotide API Manufacturing Services Introduction
11.18.4 Asymchem Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025)
11.18.5 Asymchem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oligonucleotide API Manufacturing Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ASO
Table 3. Key Players of siRNA
Table 4. Key Players of miRNA
Table 5. Key Players of saRNA
Table 6. Key Players of Aptamer
Table 7. Key Players of Others
Table 8. Global Oligonucleotide API Manufacturing Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Oligonucleotide API Manufacturing Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Oligonucleotide API Manufacturing Services Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Oligonucleotide API Manufacturing Services Market Share by Region (2020-2025)
Table 12. Global Oligonucleotide API Manufacturing Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Oligonucleotide API Manufacturing Services Market Share by Region (2026-2031)
Table 14. Oligonucleotide API Manufacturing Services Market Trends
Table 15. Oligonucleotide API Manufacturing Services Market Drivers
Table 16. Oligonucleotide API Manufacturing Services Market Challenges
Table 17. Oligonucleotide API Manufacturing Services Market Restraints
Table 18. Global Oligonucleotide API Manufacturing Services Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Oligonucleotide API Manufacturing Services Market Share by Players (2020-2025)
Table 20. Global Top Oligonucleotide API Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide API Manufacturing Services as of 2024)
Table 21. Ranking of Global Top Oligonucleotide API Manufacturing Services Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Oligonucleotide API Manufacturing Services Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Oligonucleotide API Manufacturing Services, Headquarters and Area Served
Table 24. Global Key Players of Oligonucleotide API Manufacturing Services, Product and Application
Table 25. Global Key Players of Oligonucleotide API Manufacturing Services, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oligonucleotide API Manufacturing Services Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Oligonucleotide API Manufacturing Services Revenue Market Share by Type (2020-2025)
Table 29. Global Oligonucleotide API Manufacturing Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Oligonucleotide API Manufacturing Services Revenue Market Share by Type (2026-2031)
Table 31. Global Oligonucleotide API Manufacturing Services Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Oligonucleotide API Manufacturing Services Revenue Market Share by Application (2020-2025)
Table 33. Global Oligonucleotide API Manufacturing Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Oligonucleotide API Manufacturing Services Revenue Market Share by Application (2026-2031)
Table 35. North America Oligonucleotide API Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Oligonucleotide API Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Oligonucleotide API Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Oligonucleotide API Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Oligonucleotide API Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Oligonucleotide API Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Oligonucleotide API Manufacturing Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Oligonucleotide API Manufacturing Services Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Oligonucleotide API Manufacturing Services Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Oligonucleotide API Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Oligonucleotide API Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Oligonucleotide API Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Oligonucleotide API Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Oligonucleotide API Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Oligonucleotide API Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
Table 50. Danaher(IDT) Company Details
Table 51. Danaher(IDT) Business Overview
Table 52. Danaher(IDT) Oligonucleotide API Manufacturing Services Product
Table 53. Danaher(IDT) Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 54. Danaher(IDT) Recent Development
Table 55. Merck Company Details
Table 56. Merck Business Overview
Table 57. Merck Oligonucleotide API Manufacturing Services Product
Table 58. Merck Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 59. Merck Recent Development
Table 60. Eurofins Scientific Company Details
Table 61. Eurofins Scientific Business Overview
Table 62. Eurofins Scientific Oligonucleotide API Manufacturing Services Product
Table 63. Eurofins Scientific Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 64. Eurofins Scientific Recent Development
Table 65. Thermo Fisher Scientific Company Details
Table 66. Thermo Fisher Scientific Business Overview
Table 67. Thermo Fisher Scientific Oligonucleotide API Manufacturing Services Product
Table 68. Thermo Fisher Scientific Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 69. Thermo Fisher Scientific Recent Development
Table 70. Agilent Technologies Company Details
Table 71. Agilent Technologies Business Overview
Table 72. Agilent Technologies Oligonucleotide API Manufacturing Services Product
Table 73. Agilent Technologies Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 74. Agilent Technologies Recent Development
Table 75. Nippon Shokubai Company Details
Table 76. Nippon Shokubai Business Overview
Table 77. Nippon Shokubai Oligonucleotide API Manufacturing Services Product
Table 78. Nippon Shokubai Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 79. Nippon Shokubai Recent Development
Table 80. Eurogentec Company Details
Table 81. Eurogentec Business Overview
Table 82. Eurogentec Oligonucleotide API Manufacturing Services Product
Table 83. Eurogentec Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 84. Eurogentec Recent Development
Table 85. Ajinomoto Bio-Pharma Company Details
Table 86. Ajinomoto Bio-Pharma Business Overview
Table 87. Ajinomoto Bio-Pharma Oligonucleotide API Manufacturing Services Product
Table 88. Ajinomoto Bio-Pharma Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 89. Ajinomoto Bio-Pharma Recent Development
Table 90. PeptiStar Company Details
Table 91. PeptiStar Business Overview
Table 92. PeptiStar Oligonucleotide API Manufacturing Services Product
Table 93. PeptiStar Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 94. PeptiStar Recent Development
Table 95. Bachem Company Details
Table 96. Bachem Business Overview
Table 97. Bachem Oligonucleotide API Manufacturing Services Product
Table 98. Bachem Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 99. Bachem Recent Development
Table 100. CordenPharma Company Details
Table 101. CordenPharma Business Overview
Table 102. CordenPharma Oligonucleotide API Manufacturing Services Product
Table 103. CordenPharma Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 104. CordenPharma Recent Development
Table 105. Guangzhou RiboBio Company Details
Table 106. Guangzhou RiboBio Business Overview
Table 107. Guangzhou RiboBio Oligonucleotide API Manufacturing Services Product
Table 108. Guangzhou RiboBio Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 109. Guangzhou RiboBio Recent Development
Table 110. Hongene Biotech Company Details
Table 111. Hongene Biotech Business Overview
Table 112. Hongene Biotech Oligonucleotide API Manufacturing Services Product
Table 113. Hongene Biotech Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 114. Hongene Biotech Recent Development
Table 115. WuXi AppTec Company Details
Table 116. WuXi AppTec Business Overview
Table 117. WuXi AppTec Oligonucleotide API Manufacturing Services Product
Table 118. WuXi AppTec Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 119. WuXi AppTec Recent Development
Table 120. Veliter Company Details
Table 121. Veliter Business Overview
Table 122. Veliter Oligonucleotide API Manufacturing Services Product
Table 123. Veliter Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 124. Veliter Recent Development
Table 125. Ribobay Pharma Company Details
Table 126. Ribobay Pharma Business Overview
Table 127. Ribobay Pharma Oligonucleotide API Manufacturing Services Product
Table 128. Ribobay Pharma Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 129. Ribobay Pharma Recent Development
Table 130. ChemExpress Company Details
Table 131. ChemExpress Business Overview
Table 132. ChemExpress Oligonucleotide API Manufacturing Services Product
Table 133. ChemExpress Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 134. ChemExpress Recent Development
Table 135. Asymchem Company Details
Table 136. Asymchem Business Overview
Table 137. Asymchem Oligonucleotide API Manufacturing Services Product
Table 138. Asymchem Revenue in Oligonucleotide API Manufacturing Services Business (2020-2025) & (US$ Million)
Table 139. Asymchem Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Authors List of This Report


List of Figures
Figure 1. Oligonucleotide API Manufacturing Services Picture
Figure 2. Global Oligonucleotide API Manufacturing Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oligonucleotide API Manufacturing Services Market Share by Type: 2024 VS 2031
Figure 4. ASO Features
Figure 5. siRNA Features
Figure 6. miRNA Features
Figure 7. saRNA Features
Figure 8. Aptamer Features
Figure 9. Others Features
Figure 10. Global Oligonucleotide API Manufacturing Services Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Oligonucleotide API Manufacturing Services Market Share by Application: 2024 VS 2031
Figure 12. Pharmaceuticals Case Studies
Figure 13. Scientific Research Case Studies
Figure 14. Oligonucleotide API Manufacturing Services Report Years Considered
Figure 15. Global Oligonucleotide API Manufacturing Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Oligonucleotide API Manufacturing Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Oligonucleotide API Manufacturing Services Market Share by Region: 2024 VS 2031
Figure 18. Global Oligonucleotide API Manufacturing Services Market Share by Players in 2024
Figure 19. Global Oligonucleotide API Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Oligonucleotide API Manufacturing Services Revenue in 2024
Figure 21. North America Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Oligonucleotide API Manufacturing Services Market Share by Country (2020-2031)
Figure 23. United States Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Oligonucleotide API Manufacturing Services Market Share by Country (2020-2031)
Figure 27. Germany Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Oligonucleotide API Manufacturing Services Market Share by Region (2020-2031)
Figure 35. China Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Oligonucleotide API Manufacturing Services Market Share by Country (2020-2031)
Figure 43. Mexico Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Oligonucleotide API Manufacturing Services Market Share by Country (2020-2031)
Figure 47. Turkey Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Oligonucleotide API Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Danaher(IDT) Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 51. Merck Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 52. Eurofins Scientific Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 54. Agilent Technologies Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 55. Nippon Shokubai Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 56. Eurogentec Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 57. Ajinomoto Bio-Pharma Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 58. PeptiStar Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 59. Bachem Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 60. CordenPharma Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 61. Guangzhou RiboBio Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 62. Hongene Biotech Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 63. WuXi AppTec Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 64. Veliter Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 65. Ribobay Pharma Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 66. ChemExpress Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 67. Asymchem Revenue Growth Rate in Oligonucleotide API Manufacturing Services Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies